Shenglong Zhu - Concepedia

Author

Shenglong Zhu

Also Known As

S Zhu, S. Zhu, Sheng long Zhu, Sheng-Kai Zhu, Sheng-Long Zhu, Sheng-long Zhu, ShengLong Zhu, Shengkai Zhu, Shenglong Zhu, Xin Chen

Publications

Citations

H-Index

Concepts

All Affiliations

Jiangnan University State Key Laboratory of Food Science and Technology Northeast Agricultural University Shanghai Innovative Research Center of Traditional Chinese Medicine Chinese Academy of Sciences

About

Shenglong Zhu is an author at Jiangnan University specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	506
2	Health Sciences	5	5	253
3	Biochemistry	3	3	93
4	Engineering	1	1	29
5	Natural Sciences	1	1	14

Shenglong Zhu

Publications

874

Citations

H-Index

Page 1

	Year	Citations
FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway Shenglong Zhu, Lei Ma, Yunzhou Wu, Acta Biochimica et Biophysica Sinica PathologyFatty Liver DiseaseMetabolic SyndromeNonalcoholic Fatty Liver DiseaseFibroblast Growth Factor	2014	91
FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy Shenglong Zhu, Yunzhou Wu, Xianlong Ye, Molecular and Cellular Biochemistry Metabolic SyndromeMitophagyCell AutophagyHepatologyLiver Physiology	2016	69
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway Yikuan Wu, Zhengnan Ren, Shenglong Zhu, Acta Pharmacologica Sinica Metabolic SyndromeHepatologyBiochemistryNonalcoholic Fatty Liver DiseaseMedicine	2021	54
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy Yunzhou Wu, Jinjiao He, Ying An, Journal of Pharmacological Sciences	2016	44
Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1–Arih2 axis Xuan Jiang, Siyu Ji, Feng‐Lai Yuan, Journal of Cachexia Sarcopenia and Muscle	2022	41
RETRACTED ARTICLE: ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell lines Guangxiao Lin, Shenglong Zhu, Yikuan Wu, Scientific Reports	2017	36
Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes Xianlong Ye, Jianying Qi, Dan Yu, Journal of Diabetes and its Complications Translational MedicineDiabetes ManagementMedicineInsulin GlargineDiabetes	2017	30
Co-delivery of Interleukin-12 and doxorubicin loaded Nano-delivery system for enhanced immunotherapy with polarization toward M1-type Macrophages Tushuai Li, Zhihong Liu, Xiao Fu, European Journal of Pharmaceutics and Biopharmaceutics InflammationNanomedicineCell-based Drug DeliveryNano-delivery SystemEngineering	2022	29
Free fatty acid receptor 4 deletion attenuates colitis by modulating Treg Cells via ZBED6-IL33 pathway Shenglong Zhu, Jingwei Zhang, Xuan Jiang, EBioMedicine	2022	27
Vitamin D enhances omega‐3 polyunsaturated fatty acids‐induced apoptosis in breast cancer cells Jing Yang, Shenglong Zhu, Guangxiao Lin, Cell Biology International	2017	26

Page 1